China
Firm | Deal | Value | Client | Lawyer(s) involved |
Ashurst | China Medical System’s acquisition of two heart drugs from AstraZeneca | $500 million | China Medical System Holdings | Lina Lee, Joshua Cole, Neil Cuninghame (Partners)
Alistair Tso, Edith Ma (Associates) |
Cravath Swain & Moore |
| IBM |
| |
Cleary Gottlieb Steen & Hamilton | Citigroup’s sale of minority stake in China Guangfa bank to China Life Insurance | $3 billion | China Life Insurance |
|
Davis Polk & Wardwell | UCAR Technology’s acquisition of shares in CAR Inc. from Hertz | $240 million | UCAR Technology Inc | Paul Chow, Li He (Partners)
Yang Chu, Kai Sun (Associates) |
Fangda Partners | China Medical System’s acquisition of two heart drugs from AstraZeneca | $500 million | AstraZeneca |
|
Freshfields Bruckhaus Deringer | $4.8 billion | CITIC Limited | Calvin Lai, Philip Li (Partners)
| |
Greenberg Traurig Maher | China Medical System’s acquisition of two heart drugs from AstraZeneca | $500 million | AstraZeneca |
|
Haiwen & Partners | Citigroup’s sale of minority stake in China Guangfa bank to China Life Insurance | $3 billion | China Life Insurance | Bian Hao (Partner)
|
Jin Mao |
| IBM |
| |
Jingtian & Gongcheng | $4.8 billion | China Overseas Land & Investment Limited |
| |
Jingcheng Tongda & Neal | Citigroup’s sale of minority stake in China Guangfa bank to China Life Insurance | $3 billion | Citigroup |
|
JunHe LLP | $4.8 billion | CITIC Limited |
| |
Linklaters | UCAR Technology’s acquisition of shares in CAR Inc. from Hertz | $240 million | Hertz Global Holding |
|
Norton Rose Fulbright | $4.8 billion | China Overseas Land & Investment Limited | Psyche Tai (Partner)
Doris Ng, Timothy Lam Jaycen Liao (Associates) | |
Skadden, Arps, Slate, Meagher & Flom | Shandong Hongda’s acquisition of UK game developer Jagex Limited | $300 million | Shandong Hongda Mining | Peter Huang, Daniel Dusek, John Adebiyi, Scott Hopkins, Bruce Goldner (Partners)
Andre Zhu, Alex Jupp (Counsel) Helena Derbyshire (Of Counsel)
Ning Dong, Radhika Rani, Helena Pires, Jenna Skoller, Jisun Choi (Associates) |
Skadden, Arps, Slate, Meagher & Flom | Citigroup’s sale of minority stake in China Guangfa bank to China Life Insurance | $3 billion | Citigroup | Rajeev Duggal, Jonathan Stone, Stuart Finkelstein, Brian Krause, Erica Schohn, Peter Huang, Chris Betts (Partners)
Jonathan Wisebrod (Counsel)
Mike Kung, Olivia Odell, Valarie Ney, Diana Backhouse (Associates) |
Hong Kong
Firm | Deal | Value | Client | Lawyer(s) involved |
Freshfields Bruckhaus Deringer | Zheshang Bank’s IPO | $1.75 billion | Advisor to the Bank |
|
Maples and Calder | Sinco Pharmaceuticals’ IPO | HK$320 million ($41.2 million) | Sinco Pharmaceuticals Holdings Limited | Jenny Nip (Partner)
Juno Huang (Associate) |
Commerce & Finance Law Offices | Union Medical Healthcare IPO | $96 million | Union Medical Healthcare Limited |
|
Conyers Dill & Pearman | Union Medical Healthcare IPO | $96 million | Union Medical Healthcare Limited |
|
Dentons | Union Medical Healthcare IPO | $96 million | Union Medical Healthcare Limited | Gordon Ng, Guangqin Wei, John Harrington, Timothy Santoli (Partners)
Edward Leung (Registered Foreign Lawyer)
Ignatius Seu, Curtis Stefanak (Counsel)
Shania Tsang (Associate) |
Duarte Santos | Union Medical Healthcare IPO | $96 million | Union Medical Healthcare Limited |
|
Jingtian & Gongcheng | Union Medical Healthcare IPO | $96 million | Underwriters |
|
Shearman & Sterling | Sinco Pharmaceuticals’ IPO | HK$320 million ($41.2 million) | Sinco Pharmaceuticals Holdings Limited | Alan Yeung, Paloma Wang (Partners)
Wanda Woo, Marshall Chu, Yuanjing Chen (Associates) |
Slaughter and May | Union Medical Healthcare IPO | $96 million | Underwriters |
|
Skadden, Arps, Slate, Meagher & Flom | Sinco Pharmaceuticals’ IPO | HK$320 million ($41.2 million) | Sole sponsor: China Merchants Securities (HK) Co., Limited |
|
Tang Weng Hang | Union Medical Healthcare IPO | $96 million | Union Medical Healthcare Limited |
|
Zhejiang T&C Law Firm | Zheshang Bank’s IPO | $1.75 billion |
|
|
Back to top
